Dow Chemical's US$61.7M patent-infringement verdict against NOVA Chemicals upheld by U.S. Court of Appeals

Alison Gallant

Alison Gallant

LOS ANGELES , January 24, 2012 () – The Dow Chemical Co.’s US$61.7 million patent-infringement verdict against NOVA Chemicals Corp. has been upheld by the U.S. Court of Appeals for the Federal Circuit in Washington, Bloomberg reported Jan. 24.

The original lawsuit alleged that NOVA infringed upon two of Dow’s patents, and used Dow inventions in its Surpass plastic.

NOVA had alleged both that no patent infringement had occurred, and that the patents themselves were invalid.

Dow won its case against NOVA in 2010, but the verdict was then overturned by Circuit Judge Jimmie Reyna, who accepted NOVA’S argument that Dow had transferred the patents in question to a holding company.

In the most recent decision, a majority of the three-judge panel sided with the lower-court judge and held that, despite the transfer, the patents could not be considered the creation of the holding company.

The primary source of this article is Bloomberg, New York, New York, on Jan. 24, 2012.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

Share:

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.